Hypoglycemic and Hyperglycemic Disorders

计划入组 100 人 · 首次发布于 2018 年 2 月 28 日

A Clinical Study on the Effect of Hypoglycemic Drugs on the Prognosis of Spinal Surgery in Diabetic Patients

计划入组 124 人 · 首次发布于 2022 年 1 月 28 日

Postbiotic Intervention on Vaginal Microbiota

计划入组 15 人 · 首次发布于 2025 年 12 月 11 日

hypoglycemic agents

TMA-11

Spinosad(Natroba)

C₈₃H₁₃₂N₂O₂₀

ChromaDex

United States

22nd Century

United States

Amphastar Pharmaceuticals

United States

BON Secures $32 Million Deal for Novel Postbiotic Blood Sugar Management Solution

HealthBiome Achieves Dual Regulatory Approval for Akkermansia-Based Muscle Health Ingredient

Superbrewed Food Launches Thryvia, a Shelf-Stable Protein-Derived Postbiotic for Gut and Immune Health